Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Epilepsy
100%
Ventricular Tachycardia
100%
Chronic Epilepsy
100%
Myocardial Remodeling
100%
Ventricular Repolarization
42%
Adrenergic alpha-antagonists
28%
Protein Level
28%
Electrical Properties
28%
Excitability
28%
Adrenergic Receptors
28%
QTc Interval
28%
Epileptic
28%
Sympathetic Tone
28%
Ion Channel Remodeling
28%
Sympathetic Predominance
28%
Repolarization Abnormalities
28%
Seizure
14%
Channel Protein
14%
Rodents
14%
Risk Factors
14%
Sham
14%
Myocardium
14%
Receptor-interacting Protein Kinase 1 (RIPK1)
14%
Western Blotting
14%
Beneficial Effects
14%
In Vivo Electrophysiology
14%
Ion Channels
14%
Therapeutic Target
14%
Voltage-gated K+ Channels
14%
Level Change
14%
Conduction Velocity
14%
Age-matched
14%
Cardiac Changes
14%
Adrenergic Blockade
14%
Ventricular Arrhythmia
14%
Kv4.2
14%
Electrical Excitability
14%
Arrhythmia
14%
Antagonist Treatment
14%
Epilepsy Model
14%
Electrophysiological Characteristics
14%
Optical Mapping
14%
Electrophysiological Changes
14%
Cardiac Morbidity
14%
Pilocarpine
14%
Slow Conduction
14%
Electrical Remodeling
14%
Kv4.3
14%
Corrected QT
14%
Cardiac Electrophysiology
14%
Acquired Epilepsy
14%
Medicine and Dentistry
Ventricular Tachycardia
100%
Ion Channel
100%
Excitability
75%
Repolarization
75%
Ex Vivo
50%
Adrenergic Receptor
50%
QTc Interval
50%
Adrenergic Receptor Blocking Agent
50%
Sympathetic Tone
50%
Myocardium
25%
Western Blot
25%
Receptor Protein
25%
Epileptic Seizure
25%
Cardiac Dysrhythmia
25%
Heart Ventricle Arrhythmia
25%
Electrophysiology
25%
Adrenergic Receptor Blocking
25%
Pilocarpine
25%
Voltage-Gated Potassium Channel
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ion Channel
100%
Heart Ventricle Tachycardia
100%
Adrenergic Receptor Blocking Agent
50%
Adrenergic Receptor
50%
Western Blot
25%
Receptor Protein
25%
Potassium Channel
25%
Heart Arrhythmia
25%
Heart Ventricle Arrhythmia
25%
Pilocarpine
25%